{"product_id":"pharmaceutical-innovation-incentives-competition-and-cost-benefit-analysis-in-international-perspective-hardback-9780521874908","title":"Pharmaceutical Innovation; Incentives, Competition, and Cost-Benefit Analysis in International Perspective (Hardback) 9780521874908","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePharmaceutical Innovation\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eIncentives, Competition, and Cost-Benefit Analysis in International Perspective\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eThis book reviews existing evidence and new ideas on how best to promote pharmaceutical innovation.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eFrank A. Sloan (Edited by), Chee-Ruey Hsieh (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521874908, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 30 April 2007\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e346 pages, 12 tables\u003cbr\u003e23.6 x 16 x 2.6 cm, 0.602 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\"The second section (chapters 4-7) provides the real meat of the book. The authors do an outstanding job of making a compelling case for formulating incentives for innovation based on societal needs.\" - JAMA\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThe pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Introduction Frank Sloan and Chee-Ruey Hsieh\u003cbr\u003e Part I. The Industry Structure of Pharmaceutical Innovation: 2. The pharmaceutical sector in health care Uwe Reinhardt\u003cbr\u003e 3. The economics of research and development in the pharmaceutical industry William Comanor\u003cbr\u003e Part II. Structuring Incentives for Research and Development: 4. Drugs for neglected diseases: new incentives for innovation Aidan Hollis\u003cbr\u003e 5. When patents fail: finding new drugs for the developing world Stephen M. Maurer\u003cbr\u003e 6. Implementing a public subsidy for vaccines Frank Sloan and Charles Eesley\u003cbr\u003e 7. Ensuring the future supply of vaccines: is a National Vaccine Authority the answer? Frank Lichtenberg\u003cbr\u003e Part III. Competition and Marketing: 8. Competition between generic and branded drugs Henry Grabowski\u003cbr\u003e 9. The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? Ernst Berndt\u003cbr\u003e Part IV. Public Evaluation of the Benefits and Costs of Innovation: 10. Measures of costs and benefits for drugs in cost effectiveness analysis Mark Pauly\u003cbr\u003e 11. Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience Michael Drummond\u003cbr\u003e 12. Pharmaceutical spending and health outcomes Pierre Cremieux, Denise Jarvinen, Genia Long and Phi Merrigan\u003cbr\u003e 13. Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan Chee-Ruey Hsieh, Kuang-Ta Vance Lo, Yichen Hong and Ya-Chen Tina Shih\u003cbr\u003e 14. Conclusions and policy implications Frank A. Sloan and Chee-Ruey Hsieh.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Medicine: general issues [\u003ca title=\"See our other books on Medicine: general issues\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine:%20general%20issues%20%5BMB%5D%22\"\u003eMB\u003c\/a\u003e], Political economy [\u003ca title=\"See our other books on Political economy\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Political%20economy%20%5BKCP%5D%22\"\u003eKCP\u003c\/a\u003e], Economics [\u003ca title=\"See our other books on Economics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Economics%20%5BKC%5D%22\"\u003eKC\u003c\/a\u003e], Comparative politics [\u003ca title=\"See our other books on Comparative politics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Comparative%20politics%20%5BJPB%5D%22\"\u003eJPB\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46265312772376,"sku":"9780521874908","price":45.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521874908i.jpg?v=1692021612","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/pharmaceutical-innovation-incentives-competition-and-cost-benefit-analysis-in-international-perspective-hardback-9780521874908","provider":"Freshly Printed Books","version":"1.0","type":"link"}